BP 294
Alternative Names: FUB 94Latest Information Update: 28 Nov 2007
Price :
$50 *
At a glance
- Originator Bioprojet
- Developer Bioprojet; INSERM
- Class Analgesics; Anti-inflammatories; Antiasthmatics; Antiulcers; Imidazoles
- Mechanism of Action Histamine H3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammation; Pain; Peptic ulcer